Abstract | OBJECTIVE: METHOD: One hundred patients (mean age 26.5 years, range 18-50) with a clinical diagnosis of vaginitis entered this open, noncomparative study. Each patient inserted a Neo-Penotran pessary twice daily for 14 days. Assessments were carried out at the beginning of the study and 15 and 22 days after the start of therapy. Student's t-test was used for the statistical analysis. RESULTS: Out of 100 patients who were initially recruited to the study, 20 were subsequently excluded, leaving a total of 80 patients (80%) who completed the full course of treatment. Vaginitis was resolved in 75% of cases, it improved in 18% and was unchanged in 7%. The success rate for the treatment of trichomoniasis was 80%, 93.4% for bacterial vaginosis and 84.4% for candidal vaginitis. CONCLUSION: Neo-Penotran pessaries represent a novel and effective formulation for the treatment of common types of vaginitis and this pessary may also be of particular value in the treatment of resistant or recurrent vaginitis.
|
Authors | S Kükner, T Ergin, N Ciçek, M Uğur, H Yeşilyurt, O Gökmen |
Journal | International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics
(Int J Gynaecol Obstet)
Vol. 52
Issue 1
Pg. 43-7
(Jan 1996)
ISSN: 0020-7292 [Print] United States |
PMID | 8620988
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Antifungal Agents
- Antitrichomonal Agents
- Metronidazole
- Miconazole
|
Topics |
- Adult
- Antifungal Agents
(therapeutic use)
- Antitrichomonal Agents
(therapeutic use)
- Candidiasis, Vulvovaginal
(drug therapy)
- Female
- Humans
- Metronidazole
(therapeutic use)
- Miconazole
(therapeutic use)
- Middle Aged
- Treatment Outcome
- Trichomonas Vaginitis
(drug therapy)
- Vaginosis, Bacterial
(drug therapy)
|